This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Louis A. Magnarelli, PhD

JAMA. 1989;262(24):3464-3465.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In this issue of THE JOURNAL, Schwartz and colleagues¹ report interlaboratory differences in serological test results for Lyme disease. Their findings confirm earlier results² and show that the rising number of tests performed in areas endemic for this disease can be very high. Lyme disease continues to receive major attention by the news media. Consequently, with the knowledge that the characteristic skin lesion erythema migrans may not always develop and that there is potential for long-term disorders that may be confused with other maladies, the public and the medical community have relied heavily on serum antibody tests for diagnosis. When patients are in the later stages of Lyme disease, marked by neurological or arthritic disorders, clinicians sometimes are faced with great difficulty in making a diagnosis. Like many other laboratory tests, assays for Lyme disease are less than perfect, and, as expressed by Schwartz et al,¹ some . . . [Full Text PDF of this Article]

Author Affiliations
The Connecticut Agricultural Experiment Station New Haven, Conn

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?